Catalyst Pharmaceutical Research (CPR) Company Profile

12:34 EST 20th November 2017 | BioPortfolio

Catalyst Pharmaceutical Research (CPR) is an integrated clinical research organization providing high-quality clinical research, biostatistics and data processing, regulatory, and licensing services support for pharmaceutical development. CPR's experienced staff applies industry proven information technology systems for rapid and reliable trial management, and electronic data capture and analysis, for Phase II and III multi-center international studies. This speeds project timelines, and reduces our clients overall development costs, while ensuring the highest level of security, accuracy and reliability


1111 S. Arroyo Pkwy., Suite 200
United States of America


Phone: 626-568-8645
Fax: 626-568-8667

News Articles [772 Associated News Articles listed on BioPortfolio]

INC Research launches Psychiatry Catalyst Site Network

INC Research Holdings, Inc., a leading, global phase I to IV contract research organization, has announced the launch of the Company’s Psychiatry Catalyst Site Network as part of its Catalyst progra...

STA to open catalyst screening centre in Changzhou in November

STA Pharmaceutical Co is setting up a metal catalyst-screening center at its facility in Changzhou, China.

INC Research Expands Catalyst Program

Psychiatry Catalyst Site Network aims to enhance patient focus and optimize study delivery

10 SU2C Catalyst® collaborative clinical trial projects combine treatments from 9 pharma

(Entertainment Industry Foundation) 10 SU2C Catalyst® clinical trial projects awarded, collaborating across academic /industry borders, and correlated translational research will deepen understanding...

Analysts Expect Catalyst Pharmaceuticals, Inc. (CPRX) to Announce -$0.06 Earnings Per Share

Equities research analysts expect Catalyst Pharmaceuticals, Inc. to post earnings per share of for the current quarter, according to Zacks Investment Research . Zero analysts have provided estimates f...

Stand Up To Cancer Catalyst Launches 10 Clinical Trial Projects Combining Cancer Treatments from 9 Different Pharmaceutical Companies to Explore Innovative Approaches and Find New Indications for Blockbuster Drugs from Major Companies to Improve Pa

PHILADELPHIA, Oct. 12, 2017 /PRNewswire-USNewswire/ -- Stand Up To Cancer (SU2C) has awarded 10 SU2C Catalyst clinical trial projects in which researchers from more than 30 institutions collaborate ac...

Health Catalyst Launches Data Operating System to Leapfrog Traditional Data Warehousing

Health Catalyst, a provider of healthcare analytics, decision support and outcomes improvement has launched the Health Catalyst Data Operating System (DOS), a breakthrough engineering approach that co...

Catalyst Launches Waterproof, Drop Proof Case for New 9.7-inch iPad at IFA 2017 in Berlin

Full line of Catalyst products now available from Catalyst through Amazon Germany, United Kingdom, France, Spain, Italy and the United States with Fulfillment by Amazon BERLIN, Aug. 31, 2017 /PRNe...

PubMed Articles [1803 Associated PubMed Articles listed on BioPortfolio]

The Infernal Alternatives of Corporate Pharmaceutical Research: Abandoning Psychiatry.

What happens when health research is measured by market size, how does this change the dynamics of medical research, and how is it growth envisioned and managed? Building on my arguments in Drugs for ...

Guiding principles of value creation through collaborative innovation in pharmaceutical research.

Open innovation has become the main trend in pharmaceutical research. Potential obstacles and pitfalls of collaborations often lead to missed opportunities and/or poorly executed partnerships. This pa...

Patent Highlights April-May 2017.

A snapshot of noteworthy recent developments in the patent literature of relevance to pharmaceutical and medical research and development.

Cucurbit7uril: an emerging candidate for pharmaceutical excipients.

Cucurbit[7]uril (CB[7]), belonging to the cucurbit[n]uril family (CB[n], n = 5-8, 10, or 13-15), may form host-guest complexes with a variety of small molecules of biomedical interest. The physical an...

A randomized controlled trial of the impact of pharmacist-led patient-centered pharmaceutical care on patients' medicine therapy-related quality of life.

Due to a lack of pharmaceutical care (PC)-specific measures for health-related quality of life, a novel generic questionnaire "Patient-Reported Outcomes Measure of Pharmaceutical Therapy for Quality o...

Clinical Trials [1218 Associated Clinical Trials listed on BioPortfolio]

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...

Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older

The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older...

Pharmaceutical Care Service in Diabetes

The purpose of this study is to examine the effectiveness of pharmaceutical care service in the management of poorly controlled type 2 diabetes mellitus.

Companies [3072 Associated Companies listed on BioPortfolio]

Catalyst Pharmaceutical Partners, Inc.

Catalyst Pharmaceutical Partners, Inc. is a specialty pharmaceutical company focused on the development and commercialization of prescription drugs targeting rare (orphan) neuromu...

Catalyst Pharmaceutical Research (CPR)

Catalyst Pharmaceutical Research (CPR) is an integrated clinical research organization providing high-quality clinical research, biostatistics and data processing, regulatory, and licensing services s...

Catalyst Pharmaceutical Partners

Catalyst is a specialty pharmaceutical company of Coral Gables, Florida, that acquires or in-licenses, develops and commercializes prescription drugs for the treatment of drug addiction. Catalyst is d...

Catalyst Biomedica Limited

Catalyst BioMedica is a company that enables and supports the translation of fundamental biomedical research into innovative products and technologies that will meet global healthcare needs. Catalyst ...

Catalyst Health and Technology Partners

Catalyst Health and Technology Partners (“Catalyst”), is a venture capital firm dedicated to helping promising early-stage health care, life science, and technology ventures grow.Catalyst is focus...

More Information about "Catalyst Pharmaceutical Research (CPR)" on BioPortfolio

We have published hundreds of Catalyst Pharmaceutical Research (CPR) news stories on BioPortfolio along with dozens of Catalyst Pharmaceutical Research (CPR) Clinical Trials and PubMed Articles about Catalyst Pharmaceutical Research (CPR) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Catalyst Pharmaceutical Research (CPR) Companies in our database. You can also find out about relevant Catalyst Pharmaceutical Research (CPR) Drugs and Medications on this site too.

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Corporate Database Quicklinks

Searches Linking to this Company Record